# Design and preclinical feasibility of a pediatric heart valve stent that spontaneously adapts to growth via a spring mechanism

**Authors:** Giselle Ventura, Masaki Kajimoto, Mossab Saeed, J. Scott Malloy, Ian McGinty, Lyubomyr Bohuta, Kevin A. Charette, Kyle Bilodeau, Gianna Dafflisio, Shannen B. Kizilski, Peter E. Hammer, John P. Carney, David W. Sutherland, Baturalp Arslan, Daniel F. King, David J. Carter, Sitaram M. Emani, Michael A. Portman, Corin Williams

PMC · DOI: 10.1126/sciadv.adw4669 · Science Advances · 2026-02-18

## TL;DR

A new pediatric heart valve stent can adapt to growth without invasive procedures, potentially reducing surgeries for children with heart valve defects.

## Contribution

The novel contribution is a growth-adaptive heart valve stent using a springlike nitinol mechanism that expands proportionally with the patient.

## Key findings

- The stent maintained appropriate size (8-9 mm) at implantation in piglets.
- It expanded to 13 mm over 6 weeks without additional interventions.
- Acute valve function was preserved during the growth period.

## Abstract

Congenital heart valve defects often require surgical intervention for survival. Now, there are no valve prosthetics on the market that are designed for babies and toddlers who grow rapidly. Recent advancements in expandable valves hold promise for these young patients but currently require invasive balloon catheter procedures for device expansion. Here, we describe the design and preclinical feasibility of a pediatric heart valve stent that spontaneously adapts to growth via a springlike mechanism imparted by the superelastic properties of nitinol. Studies in piglets demonstrated appropriate constraint of the device to small diameters (8 to 9 millimeters) upon implantation, acute valve function, and the ability of the stent to proportionately expand with growth up to 13 millimeters after 6 weeks without subsequent interventions after implantation. We expect that the growth-adaptive stent concept could be broadly leveraged to eliminate surgeries and invasive procedures as young patients grow.

A pediatric heart valve stent that spontaneously “grows” could reduce surgeries and invasive procedures for children.

## Linked entities

- **Chemicals:** nitinol (PubChem CID 3081502)

## Full-text entities

- **Diseases:** pulmonary atresia (MESH:D018633), LEAP (MESH:D018489), truncus arteriosus (MESH:D014339), thrombosis (MESH:D013927), transposition of the great arteries (MESH:D014188), deaths (MESH:D003643), High cardiac output (MESH:D016534), infection (MESH:D007239), CHDs (MESH:D006330), PA (MESH:D000071079), leak (MESH:D019559), ventricular arrhythmia (MESH:D001145), weight gain (MESH:D015430), stroke (MESH:D020521), PV (MESH:D011665), stenosis (MESH:D003251), tetralogy of Fallot (MESH:D013771), pannus (MESH:C537858), isolated pulmonary stenosis (MESH:D011666), congenital defects (MESH:D000013), inflammatory (MESH:D007249), Valve defects (MESH:D006349), calcification (MESH:D002114)
- **Chemicals:** CO2 (MESH:D002245), ketoprofen (MESH:D007660), heparin (MESH:D006493), buprenorphine (MESH:D002047), formalin (MESH:D005557), Anprolene AN74j (-), titanium (MESH:D014025), atropine (MESH:D001285), isoflurane (MESH:D007530), silicone (MESH:D012828), saline (MESH:D012965), oxygen (MESH:D010100), Nitinol (MESH:C013616), xylazine (MESH:D014991), ethylene oxide (MESH:D005027), polymer (MESH:D011108)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Homo sapiens (human, species) [taxon 9606], Ovis aries (domestic sheep, species) [taxon 9940], Sus scrofa (pig, species) [taxon 9823], Metazoa (animals, kingdom) [taxon 33208]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12915617/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12915617/full.md

## References

73 references — full list in the complete paper: https://tomesphere.com/paper/PMC12915617/full.md

---
Source: https://tomesphere.com/paper/PMC12915617